The management of metastatic solid tumours has historically focused on systemic treatment
given with palliative intent. However, radical surgical treatment of oligometastases is now …

Thetermoligometastases, introducedin19951 anddetailedmore recently, 2 describes an
intermediate state of cancer spread between localized disease and widespread metastases …

Background Recognizing the rapidly increasing interest and evidence in using metastasis-
directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO …

Background Development of acquired resistance limits the utility of epidermal growth factor
receptor (EGFR) tyrosine kinase inhibitors (TKI) for the treatment of EGFR-mutant lung …

Objectives The current literature on stereotactic body radiotherapy (SBRT) for
oligometastatic disease is characterized by small patient cohorts with heterogeneous …

Background The clinical state of oligometastases describes metastases limited in number
and extent, amenable to metastasis-directed therapy. We sought to analyze long-term …

Objective Soft-tissue sarcoma is a heterogeneous disease that frequently includes the
development of pulmonary metastases. The purpose of this study is to determine factors …

Oligoprogressive disease is a relatively new clinical concept describing progression at only
a few sites of metastasis in patients with otherwise controlled widespread disease. In the era …

Background The aim of this analysis was to model the effect of local control (LC) on overall
survival (OS) in patients treated with stereotactic body radiotherapy (SBRT) for liver or lung …

Purpose: To review the available options of percutaneous ablation of lung metastasis.
Methods: General indications, prognostic factors, and image guidance of percutaneous lung …